Evaluation of susceptibility locus for response to interferon-α based therapy in chronic hepatitis B patients in Chinese

被引:40
|
作者
Wu, Xiaopan [1 ]
Xin, Zhenhui [1 ]
Zhu, Xilin [1 ]
Pan, Liping [1 ]
Li, Zhuo [2 ]
Li, Hui [3 ]
Liu, Ying [1 ]
机构
[1] Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll,Sch Basic Med, Natl Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100005, Peoples R China
[2] Capital Univ Med Sci, Youan Hosp, Dept Infect Dis, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Dept Epidemiol,Sch Basic Med, Beijing 100005, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
Chronic hepatitis B; Interferon-alpha therapy; Single nucleotide polymorphism; Interleukin 28B gene; Sustained virologic response; C VIRUS-INFECTION; GENETIC POLYMORPHISMS; PLUS RIBAVIRIN; IL28B; ASSOCIATION; MANAGEMENT; CLEARANCE; MXA;
D O I
10.1016/j.antiviral.2011.12.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In 2009, three independent genome-wide association studies reported that genetic variation in the interleukin 28B gene to be associated with the response to interferon-alpha/ribavirin therapy in hepatitis C virus genotype 1 infected patients. We carried out the present study to assess whether such polymorphisms also affect the therapy effect of another interferon-alpha responsive illness as chronic hepatitis B. Five hundred and twelve interferon-alpha treatment-naive HBeAg seropositive chronic hepatitis B patients were enrolled in the present retrospective nested case-control study. All patients received PEG-IFN-alpha-2a based treatment and were examined for the therapy efficacy. SNP rs8099917 was genotyped using the Mass-Array system (Sequenom). Interestingly, the frequency of G allele of rs8099917 was significantly higher in response group than in non response group (8.3% vs. 3.9%, p = 0.003, OR = 0.44, 95%CI = 0.25-0.79). The genotype distributions of this SNP also differed significantly between two groups (p = 0.003). Our study suggested that the G allele of rs8099917 was associated with higher rate of response in HBeAg seropositive chronic hepatitis B patients treated with interferon alpha. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:297 / 300
页数:4
相关论文
empty
未找到相关数据